Ticker > Company >

Laser Eyecare share price

Boston Bio Systems Ltd.

BSE: 531458 SECTOR: Medical Equipment/Supplies/Accessories  1.28 K   0   0

8.48
-0.22 (-2.53%)
BSE: 04 Sep 04:01 PM

Price Summary

Today's High

₹ 9.1

Today's Low

₹ 8.27

52 Week High

₹ 22

52 Week Low

₹ 6.53

FinStar is Suspended!

The FinStar rating for this company is currently unavailable due to limited data disclosure. As a micro-cap company, it may carry higher risk and limited transparency. We will update the FinStar rating once more reliable data becomes available.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

5.94 Cr.

Enterprise Value

6.75 Cr.

No. of Shares

0.7 Cr.

P/E

0

P/B

1

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  8.49

CASH

0.05 Cr.

DEBT

0.87 Cr.

Promoter Holding

2.14 %

EPS (TTM)

₹  -0.73

Sales Growth

0%

ROE

-2.16 %

ROCE

-1.9%

Profit Growth

-6295.45 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 YearNA
3 YearNA
5 Year-100%

Profit Growth

1 Year-6295.45%
3 Year-512.43%
5 Year-432.23%

ROE%

1 Year-2.16%
3 Year-0.74%
5 Year-0.45%

ROCE %

1 Year-1.9%
3 Year-0.65%
5 Year-0.4%

Debt/Equity

0.1343

Price to Cash Flow

Interest Cover Ratio

0

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 2.14 0.00
Mar 2025 2.14 0.00
Dec 2024 2.14 0.00
Sep 2024 2.14 0.00
Jun 2024 2.14 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has an efficient Cash Conversion Cycle of 0 days.

 Limitations

  • The company has shown a poor profit growth of -512.430234722563% for the Past 3 years.
  • Company has a poor ROE of -0.739733333333333% over the past 3 years.
  • Company has a poor ROCE of -0.653% over the past 3 years
  • Company has low Interest coverage ratio of 0.
  • The company has a low EBITDA margin of 0% over the past 5 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
Net Sales 0 0 0 0.19 0.18
Total Expenditure 0 0.01 0.05 0.68 0.13
Operating Profit 0 -0.01 -0.05 -0.49 0.05
Other Income 0 0 0 0 0
Interest 0 0 0 0 0
Depreciation 0 0 0 0 0
Exceptional Items 0 0 0 0 0
Profit Before Tax 0 -0.01 -0.05 -0.49 0.05
Tax 0 0 0 0 0.01
Profit After Tax 0 -0.01 -0.05 -0.49 0.04
Adjusted EPS (Rs) 0 -0.01 -0.07 -0.7 0.06

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 0 0 0 0 0
Total Expenditure 0 0 0 0 0.14
Operating Profit 0 0 0 0 -0.14
Other Income 0 0 0 0 0
Interest 0 0 0 0 0
Depreciation 0 0 0 0 0
Exceptional Items 0 0 0 0 0
Profit Before Tax 0 0 0 0 -0.14
Tax 0 0 0 0 0
Net Profit 0 0 0 0 -0.14
Adjusted EPS (Rs.) 0 0 0 0 -0.2

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 7 7 7 7 7
Total Reserves -0.4 -0.41 -0.41 -0.41 -0.55
Borrowings 0.12 0.12 0.12 0.12 0.12
Other N/C liabilities 0 0 0 0 0
Current liabilities 3.86 3.86 3.86 3.86 4
Total Liabilities 10.57 10.57 10.57 10.57 10.57
Assets
Net Block 0 0 0 0 0
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 0 0 0 0 0
Loans & Advances 5.79 5.79 5.79 5.79 5.79
Other N/C Assets 0 0 0 0 0
Current Assets 4.78 4.78 4.78 4.77 4.77
Total Assets 10.57 10.57 10.57 10.57 10.57
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 0 0 0 0 -0.14
Adjustment 0 0 0 0 0
Changes in Assets & Liabilities 0 0 0 0 0.14
Tax Paid 0 0 0 0 0
Operating Cash Flow 0 0 0 0 0
Investing Cash Flow 0 0 0 0 0
Financing Cash Flow 0 0 0 0 0
Net Cash Flow 0 0 0 0 0

Corporate Actions

Investors Details

PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
promoters 2.14 2.14 2.14 2.14 2.14
jyotshna jagdishchandra s... 2.14 2.14 2.14 2.14 2.14
PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
investors 97.86 97.86 97.86 97.86 97.86
amarish jagmohan shah (hu... 1.69 1.69 1.69 1.69 1.69
amit kumar garg 1.11 1.11 1.11 1.11 1.11
anand garg 1.16 1.16 1.16 1.16 1.16
bhavna hasmukh fofani 1.11 1.11 1.11 1.11 1.11
chhaganlal keshavlal pate... 1.07 1.07 1.07 1.07 1.07
dazzel confindive ltd. 1.12 1.12 1.12 - 1.12
hetal babulal thakore 1.21 1.21 1.21 1.21 1.21
jay hasmukh fofani 1.13 1.13 1.13 1.13 1.13
karan gupta 1.24 1.24 1.24 1.24 1.24
manisha h dabhi 2.18 2.18 2.18 2.18 2.18
manubhai shah - - - 1.01 1.01
mayank doshi 2.60 2.60 2.60 2.60 2.60
rajesh kumar garg 1.33 1.33 1.33 1.33 1.33
sangita pradyuman shah 2.14 2.14 2.14 2.14 2.14
savitaben rasiklal mehta 1.17 1.17 1.17 1.17 1.11
suryansh stock and shares... - - - 1.39 1.39
tikamchand garg 1.06 1.06 1.06 1.06 1.06
bhavin shailesh kamani 1.68 1.68 1.68 1.68 -
dazzel confindive limited... - - - 1.12 -
sanjay atmaram chaudhari ... - - - 1.02 -
vinod vijayvergia 1.37 1.37 1.37 1.37 -
sobhana devi shah 1.01 1.01 1.01 - -
suryansh stock and shares... 1.39 1.39 1.39 - -

Annual Reports

Title Link
Title Link
Annual Report 2018
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Laser Eyecare Stock Price Analysis and Quick Research Report. Is Laser Eyecare an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Laser Eyecare. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Laser Eyecare has a PE ratio of -11.6884906960717 which is low and comparatively undervalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Laser Eyecare has ROA of -1.3313% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Laser Eyecare has a Current ratio of 1.1935.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Laser Eyecare has a ROE of -2.1573%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Laser Eyecare has a Debt to Equity ratio of 0.1343 which means that the company has low proportion of debt in its capital.

  • Sales growth: Laser Eyecare has reported revenue growth of 0% which is poor in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Laser Eyecare for the current financial year is 0%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Laser Eyecare is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Laser Eyecare is Rs -0.7255. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Laser Eyecare in Ticker for free. Also, one can get the intrinsic value of Laser Eyecare by using Valuation Calculators, which are available with a Finology ONE subscription. 

Laser Eyecare FAQs

Q1. What is Laser Eyecare share price today?
Ans: The current share price of Laser Eyecare is Rs 8.48.

Q2. What is the market capitalisation of Laser Eyecare?
Ans: Laser Eyecare has a market capitalisation of Rs 5.9378656 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Laser Eyecare?
Ans: The PE ratio of Laser Eyecare is -11.6884906960717 and the P/B ratio of Laser Eyecare is 0.998998645225894, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Laser Eyecare share?
Ans: The 52-week high share price of Laser Eyecare is Rs 22, and the 52-week low share price of Laser Eyecare is Rs 6.53.

Q5. Does Laser Eyecare pay dividends?
Ans: Currently, Laser Eyecare does not pay dividends. Dividend yield of Laser Eyecare is around 0%.

Q6. What are the face value and book value of Laser Eyecare shares?
Ans: The face value of Laser Eyecare shares is Rs 10, while the book value per share of Laser Eyecare is around Rs 8.4885. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Laser Eyecare?
Ans: Laser Eyecare has a total debt of Rs 0.8662 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Laser Eyecare?
Ans: The ROE of Laser Eyecare is -2.1573% and ROCE of Laser Eyecare is -1.9043%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Laser Eyecare a good buy for the long term?
Ans: The Laser Eyecare long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Laser Eyecare undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Laser Eyecare appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Laser Eyecare’s financials?
Ans: You can review Laser Eyecare’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Laser Eyecare
X